Taipei Veterans General Hospital
Taipei, 112, Taiwan
NCT Number: NCT00852514
Peritoneal dialysis (PD) is a widely used modality of renal replacement therapy. Due to its continuous nature of therapy, better control of fluid status and preservation of residual renal function were presumed by most nephrologists. However, recent evidences showed that it might not be the case. The severity of fluid overloading and the need for anti-hypertensive agents to control blood pressure seems to be more severe for PD patients. Therefore, more aggressive strategy to control dry weight is mandatory in PD patients. However, over reduction of dry weight might affect residual renal function (RRF) and, probably, the survival of PD patients. A balance between reduction of dry weight and preservation of RRF is crucial for the care of PD patients. Currently, only clinical measures like cardiothoracic ratio on chest X-ray and absence of pedal edema were used to evaluate PD patient's dry weight. There is no objective method to determine dry weight accurately. In this prospective and randomized study, the investigators will use multi-frequency bio-impedance (MF-BIA) to detect intracellular and extracellular water (ECW) content of patients.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Phase 4
Taipei, 112, Taiwan
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
for optimal determination of fluid status, monthly BIA was performed to monitor fluid status and avoid dehydration
Time frame: one year
Taipei Veterans General Hospital, Taiwan
Other Gov
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07544888
Cardiovascular Diseases, Heart Diseases
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT04705779
Body Weight, Brain Diseases
Chapel Hill, North Carolina, United States
View Trial DetailsNCT06025721
Cardiovascular Diseases, Diabetes Mellitus
Minneapolis, Minnesota, United States
View Trial DetailsNCT04508582
Cardiovascular Diseases, Cardiovascular Risk Factor
London, United Kingdom
View Trial Details